The first online exchange meeting for members of Yinfeng Life Extension Program was successfully held
Release time:
2022-12-09
On December 9, 2022, Yinfeng Life Extension Program launched the first member online exchange meeting to build a bridge to promote communication among members. This conference will have a comprehensive understanding of the new base, scientific research system and content of the life extension program, and start a scientific and technological journey through time and space for everyone.
Yinfeng Life Extension Program is a future-oriented and challenging cutting-edge life science research project. The program mainly includes the research on the cryopreservation and resuscitation of tissues and organs and the research on the cryopreservation and resuscitation of human bodies, and is committed to the use of advanced cryobiomedical technology to carry out research on the cryopreservation, resuscitation and clinical transformation application of cells, tissues and organs.
This meeting introduced in detail the technical strength of Yinfeng Bio Group in technology research and development, medical transformation and clinical research in the field of biomedicine. Among them, the Cryogenic Medicine Research Center is affiliated to Yinfeng Life Science Research Institute, which was established at the end of 2015, mainly engaged in the development of cryoprotectants, the research and development of cryoprotective equipment, tissues and organs, and human cryopreservation and resuscitation. During the meeting, we were shown a comprehensive implementation process of human cryopreservation and resuscitation research: cross-site transport, clinical standby, cryogenic perfusion, programmed cooling, and long-term preservation.
Life Extension Program Gallery
Perfusion operation room
Cooling zone - programmed pyrometer
Cryopreservation area - liquid nitrogen tank
Meeting site
Director Zang Chuanbao, director of Yinfeng Cryogenic Medical Center, gave a detailed introduction to Yinfeng's cryogenic scientific research system and content. Li Qingping, director of Yinfeng Cryogenic Member Development Center, made a substantial arrangement for the promotion plan of the life extension plan in 2023, bringing a high-quality participation experience to each member.
未来，拥有无限可能！
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
